CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,271 | -29.6% | 19,848 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $469,386 | +5.7% | 19,143 | +4.0% | 0.00% | 0.0% |
| Q1 2023 | $444,001 | -16.7% | 18,408 | +2.0% | 0.00% | -25.0% |
| Q4 2022 | $532,961 | -29.6% | 18,042 | -0.4% | 0.00% | -33.3% |
| Q3 2022 | $757,000 | +50.8% | 18,108 | +1.4% | 0.01% | +100.0% |
| Q2 2022 | $502,000 | -28.9% | 17,852 | -6.0% | 0.00% | -25.0% |
| Q1 2022 | $706,000 | -20.6% | 18,996 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $889,000 | -31.6% | 20,333 | -2.9% | 0.00% | -42.9% |
| Q3 2021 | $1,300,000 | -29.0% | 20,941 | -2.3% | 0.01% | +16.7% |
| Q2 2021 | $1,832,000 | +114.0% | 21,439 | +12.5% | 0.01% | +100.0% |
| Q1 2021 | $856,000 | +558.5% | 19,054 | +0.3% | 0.00% | – |
| Q4 2020 | $130,000 | -18.8% | 19,004 | +37.1% | 0.00% | -100.0% |
| Q3 2020 | $160,000 | +263.6% | 13,858 | -2.2% | 0.00% | – |
| Q2 2020 | $44,000 | – | 14,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |